Clinical and Laboratory Characteristics of Polycythemia Vera
NCT06134102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1150
Last updated 2024-07-18
Summary
The study is observational, longitudinal, retrospective and prospective, on patients with PV. Patients with PV diagnosed from 2000 to 2023 according to WHO2017 criteria will be considered. The main purpose of the study is to determine the impact of clinical and laboratory characteristics of Polycythemia Vera on patients' prognosis, understood as long-term survival
Conditions
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Italy
Study Locations
More Related Trials
-
STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY
NCT05286138 ·Status: RECRUITING
-
The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy
NCT06396403 ·Status: COMPLETED
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
NCT03263364 ·Status: UNKNOWN
-
Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study
NCT07282132 ·Status: NOT_YET_RECRUITING
-
Hydroxyurea in the Treatment of Sickle Cell Disease
NCT02709681 ·Status: COMPLETED
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms
NCT02823184 ·Status: COMPLETED
-
EVAluation of Erythrocytosis PRospEctive Cohort STudy
NCT06785870 ·Status: NOT_YET_RECRUITING
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis.
NCT05993065 ·Status: UNKNOWN
-
PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
NCT04925492 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
NCT05853458 ·Status: TERMINATED ·Phase: PHASE4
-
Early-goal Directed Automated Red Blood Cell Exchange for Acute Chest Syndrome in Sickle Cell Disease
NCT06214845 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
NCT01496963 ·Status: COMPLETED
-
The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
NCT03003325 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Evaluation Study for Patients With Polycythemia Vera
NCT05074550 ·Status: UNKNOWN ·Phase: PHASE1
-
Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
NCT05125341 ·Status: COMPLETED
-
Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera
NCT06290765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
NCT02809274 ·Status: UNKNOWN
-
Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events
NCT02539771 ·Status: COMPLETED ·Phase: NA
-
Study of Biological Markers in Children With Sickle Cell Disease
NCT04839159 ·Status: UNKNOWN ·Phase: NA
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
NCT05440838 ·Status: RECRUITING